ArticlePediatric transplantation2026
Machine Perfusion and Mitigating Risk Factors for Delayed Graft Function in Pediatric Kidney Transplant Recipients.
Article in Pediatric transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney transplantation confers prolonged and improved quality of life versus dialysis for patients with end-stage kidney disease (ESKD). Delayed graft function (DGF) increases the risk of allograft rejection and decreases allograft survival. In adults, prolonged warm (WIT) and cold ischemia time (CIT) increase risk of DGF, and machine perfusion (MP) during organ transportation reduces this risk. However, there is a paucity of data regarding risk factors for DGF in children.
methodsWe retrospectively evaluated risk and protective factors for DGF in patients aged 18 months to 21 years who underwent kidney transplantation at Cincinnati Children's Hospital Medical Center between 11/1/2017 and 11/30/2021. DGF was defined as receiving dialysis within 7 days post-transplant.
resultsNine of 89 (10%) patients developed DGF. Patients with DGF had longer median WIT (49 IQR: 44-57 vs. 37 min IQR: 30-43; p = 0.002) and were more likely to have received a deceased donor (DD) allograft (p = 0.04, RR1.7 (95% CI: 1.2-2.4)). There was no difference in CIT between those who did and did not experience DGF (464 IQR:329-788 vs. 271 min. IQR:271-788; p = 0.16). No patients who received DD-MP kidneys developed DGF. DGF in recipients of DD-non-MP kidneys had longer WIT (53 IQR: 43-57 vs. 36 min. IQR: 30-44; p < 0.009).
conclusionIncreased WIT increases the risk of DGF in pediatric kidney transplant recipients, whereas MP appears to be protective against DGF and may ameliorate the adverse effect of CIT. DGF was rare in the cohort and further studies are necessary due to the low incidence of DGF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.